Weight Loss Experiences of African American, Hispanic, and Non-Hispanic White Men and Women with Type 2 Diabetes: The Look AHEAD Trial.


Journal

Obesity (Silver Spring, Md.)
ISSN: 1930-739X
Titre abrégé: Obesity (Silver Spring)
Pays: United States
ID NLM: 101264860

Informations de publication

Date de publication:
08 2019
Historique:
received: 05 11 2018
accepted: 17 04 2019
entrez: 25 7 2019
pubmed: 25 7 2019
medline: 25 4 2020
Statut: ppublish

Résumé

The aim of this study was to characterize weight loss, treatment engagement, and weight control strategies utilized by African American, Hispanic, and non-Hispanic white participants in the Action for Health in Diabetes (Look AHEAD) Intensive Lifestyle Intervention by racial/ethnic and sex subgroups. Weight losses at 1, 4, and 8 years among 2,361 adults with obesity and type 2 diabetes randomized to intervention (31% minority; 42% men) are reported by subgroup. Multivariable models within subgroups examine relative contributions of treatment engagement variables and self-reported weight control behaviors. All subgroups averaged weight losses ≥ 5% in year 1 but experienced regain; losses ≥ 5% were sustained at year 8 by non-Hispanic white participants and minority women (but not men). Session attendance was high (≥ 86%) in year 1 and exceeded protocol-specified minimum levels into year 8. Individual session attendance had stronger associations with weight loss among Hispanic and African American participants than non-Hispanic white participants at 4 years (P = 0.04) and 8 years (P = 0.001). Daily self-weighing uptake was considerable in all subgroups and was a prominent factor associated with year 1 weight loss among African American men and women. Greater meal replacement use was strongly associated with poorer 1-year weight losses among African American women. Experiences of minority men and women with diabetes in lifestyle interventions fill important gaps in the literature that can inform treatment delivery.

Identifiants

pubmed: 31338998
doi: 10.1002/oby.22522
pmc: PMC6658112
mid: NIHMS1026399
doi:

Banques de données

ClinicalTrials.gov
['NCT00017953']

Types de publication

Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1275-1284

Subventions

Organisme : NIDDK NIH HHS
ID : U01 DK057151
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK057154
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK056992
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK057171
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK079626
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK057182
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK057136
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK057002
Pays : United States
Organisme : NCRR NIH HHS
ID : M01 RR001066
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK057078
Pays : United States
Organisme : NCRR NIH HHS
ID : M01 RR000043
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK057008
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK057149
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK048520
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK057135
Pays : United States
Organisme : NCRR NIH HHS
ID : UL1 RR024153
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK046204
Pays : United States
Organisme : NCRR NIH HHS
ID : M01 RR002719
Pays : United States
Organisme : NCRR NIH HHS
ID : M01 RR000056
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK057219
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK111022
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK057177
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK057131
Pays : United States
Organisme : NCRR NIH HHS
ID : M01 RR000051
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK056336
Pays : United States
Organisme : University of Tennessee at Memphis General Clinical Research Center
ID : M01RR0021140
Pays : International
Organisme : NIDDK NIH HHS
ID : U01 DK056990
Pays : United States
Organisme : NCRR NIH HHS
ID : UL1 RR025758
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK057178
Pays : United States
Organisme : NCRR NIH HHS
ID : M01 RR001346
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK017047
Pays : United States

Informations de copyright

© 2019 The Obesity Society. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.

Références

Diabetes Educ. 2005 Jul-Aug;31(4):555-63
pubmed: 16100331
Diabetes Care. 2014 Sep;37(9):2548-56
pubmed: 25147253
J Natl Med Assoc. 2009 Jan;101(1):62-70
pubmed: 19245074
Obesity (Silver Spring). 2006 May;14(5):737-52
pubmed: 16855180
JAMA. 2016 Jun 7;315(21):2284-91
pubmed: 27272580
Obesity (Silver Spring). 2008 Jun;16(6):1413-20
pubmed: 18421273
Transl Behav Med. 2015 Dec;5(4):401-14
pubmed: 26622913
Am J Public Health. 1983 Jun;73(6):691-3
pubmed: 6846677
Clin Trials. 2012 Feb;9(1):80-9
pubmed: 22064686
Public Health Rep. 1992 Sep-Oct;107(5):549-55
pubmed: 1410236
J Consult Clin Psychol. 2001 Aug;69(4):717-21
pubmed: 11550739
Obes Res. 2002 Feb;10(2):96-106
pubmed: 11836455
Obes Rev. 2014 Oct;15 Suppl 4:204-12
pubmed: 25196414
Control Clin Trials. 2003 Oct;24(5):610-28
pubmed: 14500058
Int J Obes Relat Metab Disord. 2004 Dec;28(12):1575-9
pubmed: 15467776
J Acad Nutr Diet. 2017 Jun;117(6):923-928
pubmed: 28330732
JAMA. 2003 Jan 1;289(1):76-9
pubmed: 12503980
Obesity (Silver Spring). 2017 Jan;25(1):45-55
pubmed: 27911049
Diabetes Care. 2011 Apr;34(4):838-44
pubmed: 21378213
J Am Diet Assoc. 2011 Jan;111(1):92-102
pubmed: 21185970
J Hum Hypertens. 2005 Jan;19(1):21-31
pubmed: 15385946
Obes Rev. 2010 Nov;11(11):769-76
pubmed: 20059708
Am J Public Health. 2004 Oct;94(10):1736-42
pubmed: 15451743
Int J Obes Relat Metab Disord. 2003 May;27(5):537-49
pubmed: 12704397
Diabetes Care. 2014 Jun;37(6):1544-53
pubmed: 24855155
Diabetes Care. 2008 Jul;31(7):1299-304
pubmed: 18375417
J Immigr Minor Health. 2012 Dec;14(6):1030-9
pubmed: 22460538
N Engl J Med. 2013 Jul 11;369(2):145-54
pubmed: 23796131
Obes Rev. 2014 Oct;15 Suppl 4:93-106
pubmed: 25196408
Obesity (Silver Spring). 2009 Apr;17(4):713-22
pubmed: 19180071
Obes Sci Pract. 2018 Jan 17;4(1):62-75
pubmed: 29479466
Obes Res Clin Pract. 2016 Jan-Feb;10(1):70-84
pubmed: 25937165
Obesity (Silver Spring). 2014 Jan;22(1):5-13
pubmed: 24307184
Endocr Pract. 2015 Apr;21 Suppl 1:1-87
pubmed: 25869408
Lancet Diabetes Endocrinol. 2014 Oct;2(10):801-9
pubmed: 25127483
Diab Vasc Dis Res. 2006 Dec;3(3):202-15
pubmed: 17160917
Prev Med Rep. 2016 Jun 30;4:296-302
pubmed: 27486558

Auteurs

Delia Smith West (DS)

Department of Exercise Science, University of South Carolina, Columbia, South Carolina, USA.

Gareth Dutton (G)

Division of Preventive Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Linda M Delahanty (LM)

Diabetes Research Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Helen P Hazuda (HP)

Division of Nephrology, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.

Amy D Rickman (AD)

Department of Exercise & Rehabilitative Sciences, Slippery Rock University, Slippery Rock, Pennsylvania, USA.

William C Knowler (WC)

Diabetes Epidemiology and Clinical Research Section, NIDDK, Phoenix, Arizona, USA.

Mara Z Vitolins (MZ)

Department of Epidemiology and Prevention, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.

Rebecca H Neiberg (RH)

Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.

Anne Peters (A)

Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

Molly Gee (M)

Behavioral Medicine Research Center, Baylor College of Medicine, Houston, Texas, USA.

Maria Cassidy Begay (M)

NIDDK and Indian Health Service, Shiprock, New Mexico, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH